0.92 (-%)
As of Nov 20, 2024
Source:
We are a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19.
| Country | United States |
| Headquarters | malvern, pennsylvania |
| Phone Number | 484-328-4701 |
| Industry | manufacturing |
| CEO | Shankar Musunuri |
| Website | ocugen.com |